AMZN
Amazon.com, Inc.
AMZN has the edge over PVH overall, supported by stronger valuation and stronger modeled upside.
PVH
PVH Corp.
PVH trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
PVH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Stable |
PVH's cash flow is currently healthy, and its revenue and balance sheet are stable, but its profitability is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
PVH PE Valuation
PVH has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over PVH on the outlook, with more favorable revenue and profitability expectations.
PVH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect PVH's earnings to grow, with its revenue and profitability holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over PVH on earnings quality, reporting a profit while its opponent remains loss making.
PVH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.54 | — |
| Q3 2026 | -$3.56 | -140% |
| Q2 2026 | $3.30 | -53% |
| Q1 2026 | $0.52 | -95% |
| Q4 2025 | $6.67 | -45% |
| Q3 2025 | $8.92 | -29% |
| Q2 2025 | $7.09 | -37% |
| Q1 2025 | $10.56 | -1.9% |
| Q4 2024 | $12.19 | +43% |
PVH has swung to a loss: it lost $3.56 per share over the past year, after a profit the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over PVH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over PVH on profitability, with a higher operating margin.
PVH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.1B | -3.2% |
| Q2 2026 | $2B | +2.1% |
| Q1 2026 | $2.5B | +5.6% |
| Q4 2025 | $2.3B | +1.7% |
| Q3 2025 | $2.2B | +4.5% |
| Q2 2025 | $2B | +1.6% |
| Q1 2025 | $2.4B | -4.8% |
| Q4 2024 | $2.3B | -4.6% |
PVH's revenue fell from its 2020 peak and has held roughly level since: $2.1B last quarter, down 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -9.1% | -15 points |
| Q2 2026 | 6.1% | +23 points |
| Q1 2026 | 9.9% | +1.1 points |
| Q4 2025 | 7.9% | -0.2 points |
| Q3 2025 | 6.2% | -2.2 points |
| Q2 2025 | -17% | -27 points |
| Q1 2025 | 8.9% | -5.5 points |
| Q4 2024 | 8.1% | -1.6 points |
PVH's operating margin was −9.1% last quarter, down 15 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
PVH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $346.4M | +90% |
| Q2 2026 | -$86M | +$12.1M |
| Q1 2026 | $539.7M | +22% |
| Q4 2025 | -$85.1M | -$73.8M |
| Q3 2025 | $181.9M | -29% |
| Q2 2025 | -$98.1M | +$7.4M |
| Q1 2025 | $443.2M | -23% |
| Q4 2024 | -$11.3M | -117% |
PVH has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
PVH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -300K shares |
| 1 year | -4.9% | -2.4M shares |
| 3 years | -26% | -16.6M shares |
| 5 years | -36% | -26.4M shares |
| Available history | -38% | -28.1M shares |
PVH has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2M |
| Q2 2026 | $14.9M |
| Q1 2026 | $500,000 |
| Q4 2025 | $200,000 |
| Q3 2025 | $4.8M |
| Q2 2025 | $572.2M |
| Q1 2025 | $244.6M |
| Q4 2024 | $34.8M |
PVH spent $18M buying back its own shares over the past year, down 98% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over PVH on leverage, with a lower net debt burden relative to earnings.
PVH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 4.5x | High |
| Q3 2025 | 4.3x | High |
| Q2 2025 | 4.2x | High |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.3x | Healthy |
PVH's net debt is about 2.1 years of its operating earnings (EBITDA), down from 4.3 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
PVH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.1 | Neutral |
| Stochastic | 83.7 | Overbought |
PVH's weekly RSI is 63 (neutral) and its Stochastic is 84 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
PVH PE vs Consumer Cyclical Sector
| Metric | PVH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
PVH has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
PVH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $84.4 | 9.8% above |
| 20 week MA | $80.9 | 15% above |
| 50 week MA | $77.5 | 20% above |
| 100 week MA | $78.2 | 19% above |
| 200 week MA | $88.1 | 5.2% above |
PVH has climbed back above all five of its weekly moving averages, and it's now 5.2% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
PVH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $104.1 | $93.8 | -9.8% |
| 2021 | $93.8 | $100.3 | +6.9% |
| 2022 | $100.3 | $70.1 | -30% |
| 2023 | $70.1 | $122.1 | +74% |
| 2024 | $122.1 | $107.5 | -12% |
| 2025 | $107.5 | $68.7 | -36% |
| 2026 YTD | $68.7 | $92.7 | +35% |
PVH has the edge over AMZN on returns for 2026, with the stronger performance.